Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
40,146,697
-
Share change
-
+1,434,026
-
Total reported value
-
$1,294,963,766
-
Put/Call ratio
-
200%
-
Price per share
-
$32.25
-
Number of holders
-
146
-
Value change
-
+$49,911,355
-
Number of buys
-
76
-
Number of sells
-
57
Institutional Holders of ANACOR PHARMACEUTICALS INC - COM (ANAC) as of Q4 2014
As of 31 Dec 2014,
ANACOR PHARMACEUTICALS INC - COM (ANAC) was held by
146 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,146,697 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, Palo Alto Investors, LLC, EAGLE ASSET MANAGEMENT INC, BlackRock Fund Advisors, VANGUARD GROUP INC, Point72 Asset Management, L.P., Consonance Capital Management LP, FARALLON CAPITAL MANAGEMENT LLC, and FMR LLC.
This page lists
146
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.